AAV Packaging
AAV Packaging services center around GENEWIZ from Azenta’s proprietary AAV plasmid synthesis process to provide industry-leading project quality, completion time, and flexibility.
Lentivirus Production
Lentivirus Production services provide a comprehensive set of high-titer and high-throughput lentiviral solutions, spanning construct synthesis through viral production plus storage of transduction-ready virus.
Integration Site Analysis for Cell and Gene Therapy
Integration Site Analysis, Lentivirus Integration Site Analysis, Integration Site, Integration Analysis, Site Integration, Gene Integration, Gene Sites, Gene Analysis, Long Term Follow Up, Cell Therapy, Gene Therapy, Viral Vector Integration
Biofluid Processing
GENEWIZ and Azenta Life Sciences offer a complete sample management solution via our combined services.
Nucleic Acid Extraction
GENEWIZ provides nucleic acid extraction as part of complete projects and as a standalone service. Simply provide GENEWIZ with your sample and we do the rest.
GLP-compliant Plasmid Prep
GENEWIZ Good Laboratory Practices endotoxin-free plasmid DNA preparation services, including animal-free plasmid preparations, are FDA and EPA GLP compliant to accelerate pre-clinical development of therapeutics for clients in biotechnology, pharmaceuticals, and other industries.
GLP-compliant SNP Mutation Analysis
GENEWIZ SNP/Mutation Analysis is designed to follow Good Laboratory Practice (GLP), Good Manufacturing Practice (GMP) as applicable to our services, and Good Clinical Practice (GCP) guidelines.
GLP-compliant Confirmatory Sequencing
GENEWIZ’s Confirmatory Sequencing under Good Laboratory Practice (GLP) guidelines provides confirmation of the biologic using Sanger sequencing to support FDA- and EPA- submissions.
GLP-Compliant Services (Regulatory)
Good Laboratory Practice (GLP) services from GENEWIZ are designed to be compliant with US FDA (21 CFR Part 58) and US EPA (40 CFR Part 160) regulations to support pre-marketing authorizations.
Clinical Genome Sequencing (CLIA / CAP)
Clinical Genome Sequencing provides a CLIA-validated comprehensive analysis of the entire genome to uncover mutations in coding and non-coding regions, including structural and copy number variants.